TScan Therapeutics, Inc.
Key Metrics
Market Snapshot
About
TScan Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing T cell receptor-engineered T cell (TCR-T) therapies for the treatment of cancer. The company uses its proprietary technology platform to identify novel cancer targets and engineer T cells to recognize and destroy tumor cells. TScan focuses on addressing both solid tumors and hematologic malignancies.